Pinnacle Wealth Planning Services, Inc. Gilead Sciences, Inc. Transaction History

Pinnacle Wealth Planning Services, Inc.

$733 Million
Q3 2024

A detailed history of Pinnacle Wealth Planning Services, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Pinnacle Wealth Planning Services, Inc. holds 7,703 shares of GILD stock, worth $692,345. This represents 0.09% of its overall portfolio holdings.

Number of Shares

7,703

Previous 7,760 0.73%

Holding current value

$692,345

Previous $532,000 21.24%

% of portfolio

0.09%

Previous 0.08%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$66.59 - $83.99 $3,795 - $4,787	-57 Reduced 0.73%	7,703 $645,000
Q2 2024 Aug 09, 2024	SELL	$63.15 - $72.88 $7,956 - $9,182	-126 Reduced 1.6%	7,760 $532,000
Q1 2024 May 09, 2024	SELL	$71.58 - $87.29 $68,287 - $83,274	-954 Reduced 10.79%	7,886 $577,000
Q4 2023 Feb 07, 2024	SELL	$73.27 - $83.09 $10,697 - $12,131	-146 Reduced 1.62%	8,840 $716,000
Q3 2023 Nov 07, 2023	SELL	$73.94 - $80.67 $4,288 - $4,678	-58 Reduced 0.64%	8,986 $673,000
Q2 2023 Aug 07, 2023	SELL	$76.01 - $86.7 $13,377 - $15,259	-176 Reduced 1.91%	9,044 $697,000
Q1 2023 May 03, 2023	SELL	$77.31 - $88.08 $231 - $264	-3 Reduced 0.03%	9,220 $764,000
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $14,832 - $21,293	-238 Reduced 2.52%	9,223 $791,000
Q3 2022 Nov 09, 2022	BUY	$59.54 - $68.01 $19,231 - $21,967	323 Added 3.53%	9,461 $583,000
Q2 2022 Aug 03, 2022	BUY	$57.72 - $65.01 $153,939 - $173,381	2,667 Added 41.21%	9,138 $565,000
Q1 2022 Apr 20, 2022	SELL	$57.92 - $72.58 $75,006 - $93,991	-1,295 Reduced 16.68%	6,471 $385,000
Q4 2021 Jan 21, 2022	BUY	$64.88 - $73.64 $19,593 - $22,239	302 Added 4.05%	7,766 $564,000
Q3 2021 Oct 29, 2021	BUY	$67.69 - $73.03 $19,359 - $20,886	286 Added 3.98%	7,464 $521,000
Q2 2021 Aug 02, 2021	BUY	$63.47 - $69.35 $24,689 - $26,977	389 Added 5.73%	7,178 $494,000
Q1 2021 Apr 29, 2021	BUY	$60.0 - $68.46 $105,420 - $120,284	1,757 Added 34.92%	6,789 $438,000
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $30,081 - $34,276	-531 Reduced 9.55%	5,032 $293,000
Q3 2020 Nov 03, 2020	SELL	$62.1 - $78.08 $47,817 - $60,121	-770 Reduced 12.16%	5,563 $352,000
Q2 2020 Jul 27, 2020	SELL	$72.34 - $84.0 $12,731 - $14,784	-176 Reduced 2.7%	6,333 $487,000
Q1 2020 May 11, 2020	BUY	$62.63 - $80.22 $65,323 - $83,669	1,043 Added 19.08%	6,509 $485,000
Q4 2019 Feb 07, 2020	BUY	$61.62 - $67.78 $57,244 - $62,967	929 Added 20.48%	5,466 $355,000
Q3 2019 Oct 31, 2019	BUY	$62.51 - $69.0 $52,508 - $57,960	840 Added 22.72%	4,537 $287,000
Q2 2019 Aug 06, 2019	BUY	$61.87 - $69.38 $228,733 - $256,497	3,697 New	3,697 $249,000
Q4 2018 Mar 01, 2019	SELL	$60.54 - $79.0 $215,219 - $280,845	-3,555 Closed	0 $0
Q3 2018 Feb 28, 2019	BUY	$71.28 - $78.92 $7,484 - $8,286	105 Added 3.04%	3,555 $274,000
Q2 2018 Feb 28, 2019	SELL	$64.88 - $75.68 $10,770 - $12,562	-166 Reduced 4.59%	3,450 $244,000
Q1 2018 Feb 28, 2019	BUY	$72.84 - $88.8 $263,389 - $321,100	3,616 New	3,616 $273,000

Others Institutions Holding GILD

# of Institutions

1,931

Shares Held

991M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Wealth Planning Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Wealth Planning Services, Inc. with notifications on news.

Account

Pinnacle Wealth Planning Services, Inc. Gilead Sciences, Inc. Transaction History